Related Experiment Video
Updated: Oct 2, 2026
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
Strategies for blocking the systemic effects of cytokines in the sepsis syndrome
J W Christman1, E P Holden, T S Blackwell
1Department of Veterans Affairs, Nashville, TN, USA.
Objectives:
To review and evaluate animal and human data regarding strategies to intervene in the pathogenesis of the sepsis syndrome by specifically blocking the action of single cytokines.
Data Sources:
The English language medical literature was reviewed, including reports of human clinical trials, animal experiments, and in vitro studies elucidating cellular and molecular interactions.
Study Selection:
Emphasis was placed on controlled experimental studies that elucidated the effectiveness of antibodies, soluble receptors, and receptor antagonists in intervening in the pathogenesis of the sepsis reaction.
Data Extraction:
This review focuses on data that directly involve the induction and regulation of protein mediators of sepsis, especially tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-8.
Data Synthesis:
Information concerning the potential of cytokine blockers in modulating the sepsis reaction is presented in a logical, clinically oriented fashion. The purpose is to emphasize the potential role of these agents by focusing on the actual existing data.
Conclusions:
The pathophysiology of the sepsis reaction appears to involve the sequential release of cytokines. Interventions designed to specifically block the biological effects of single cytokines appear to have a role in the management of sepsis syndrome, but well-designed, prospective, randomized, placebo-controlled clinical trials in well-defined clinical populations are necessary to define this role. These trials require the cooperation of clinical and basic scientists.
Insights
Targeting single cytokines shows promise for managing sepsis. Further clinical trials are needed to confirm the effectiveness of these cytokine blockers in sepsis treatment.
Area of Science:
- Immunology and Inflammation Research
- Sepsis Pathogenesis and Treatment
Background:
- Sepsis syndrome involves a complex, sequential release of cytokines.
- Understanding cytokine regulation is crucial for developing effective sepsis interventions.
Purpose of the Study:
- To review and evaluate existing animal and human data on single cytokine blockade strategies for sepsis.
- To assess the potential role of cytokine blockers in modulating sepsis pathogenesis.
Main Methods:
- Comprehensive review of English language medical literature, including clinical trials, animal experiments, and in vitro studies.
- Focus on controlled studies evaluating antibodies, soluble receptors, and receptor antagonists.
- Emphasis on data related to tumor necrosis factor-alpha, interleukin-1 beta, -6, and -8.
Main Results:
- Data suggests that blocking specific cytokines can modulate the sepsis reaction.
- Information is presented to highlight the potential of cytokine blockers based on existing evidence.
Conclusions:
- Specific cytokine blockade appears to have a potential role in sepsis management.
- Well-designed, randomized, placebo-controlled clinical trials are essential to define this role.
- Collaboration between clinical and basic scientists is necessary for future research.
Related Concept Videos
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:28Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:25Acute Inflammation III: Local and Systemic Effects